Vanguard Group Inc Nexalin Technology, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 31,780 shares of NXL stock, worth $21,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,780Holding current value
$21,292% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NXL
# of Institutions
14Shares Held
276KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY59.8KShares$40,0690.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE55.5KShares$37,1590.81% of portfolio
-
Geode Capital Management, LLC Boston, MA44.1KShares$29,5210.0% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY38.4KShares$25,7360.0% of portfolio
-
State Street Corp Boston, MA16.8KShares$11,2560.0% of portfolio
About Nexalin Technology, Inc.
- Ticker NXL
- Exchange
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 7,279,960
- Market Cap $4.88M